Sun Pharma Q1 Results FY26: Sun Pharmaceutical Industries reported a 20% fall in Q1 consolidated net profit, reaching Rs 2,278 crore. Despite this dip, revenue from operations increased by 10% to Rs 13,786 crore. Strong performance in the India market and growth in global innovative medicines sales, including the U.S. launch of LEQSELVI, contributed to the company’s overall progress.
Network18 Q4 loss at Rs 29.61 crore, revenue up 9.7% to Rs 615.78 cr
Network18 Media & Investments reported a consolidated net loss of Rs 29.61 crore for the March quarter, despite a 9.7% rise in operational revenue to